AnergiX-IDDM

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAnergiX-IDDM
Drug Alias Nameantigen specific therapy (Corixa)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressantsApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCorixa Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/SCorixa Corp
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A